ULISSE BIOMED SPA (UBM.MI) Stock Cash Flow
BIT:UBM - Euronext Milan - IT0005451213 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.94M | -2.47M | -1.31M | -603.60K | 221.80K | |||
| Depreciation Amortization | 2.92M | 330.10K | 319.60K | 247.70K | 50.90K | |||
| Change In Working Capital | -499.10K | 742.60K | 171.30K | 92.10K | -778.80K | |||
| Other non cash items | N/A | 14.50K | -153.70K | -131.00K | -95.40K | |||
| OPERATING CASH FLOW | -3.52M | -1.39M | -970.50K | -394.80K | -601.50K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -34.80K | -98.60K | -227.90K | -955.70K | -108.00K | |||
| Other Investing Activity | -6.10K | 100.00 | 0.00 | -2.30K | -800.00 | |||
| INVESTING CASH FLOW | -40.90K | -98.50K | -227.90K | -958.00K | -108.80K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -39.20K | 0.00 | 2.50K | 6.30M | -2.20K | |||
| Stock Issued/Repurchased | N/A | N/A | 2.50K | 6.30M | N/A | |||
| Other Financing Activity | 2.26M | N/A | N/A | 0.00 | -20.70K | |||
| FINANCING CASH FLOW | 2.23M | 0.00 | 2.50K | 6.30M | -23.00K | |||
| CHANGE IN CASH | -1.33M | -1.48M | -1.20M | 4.95M | -733.20K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.52M | -1.39M | -970.50K | -394.80K | -601.50K | |||
| Capital Expenditure | -34.80K | -98.60K | -227.90K | -955.70K | -108.00K | |||
| FREE CASH FLOW | -3.55M | -1.48M | -1.20M | -1.35M | -709.50K | |||
All data in EUR